The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
Abstract
A number of pharmacologic treatments examined in recent randomized clinical trials (RCTs) have failed to show statistically significant superiority to placebo in conditions in which their efficacy had previously been demonstrated. Assuming the validity of previous evidence of efficacy and the comparability of the patients and outcome measures in these studies, such results may be a consequence of limitations in the ability of these RCTs to demonstrate the benefits of efficacious analgesic treatments vs placebo ("assay sensitivity"). Efforts to improve the assay sensitivity of analgesic trials could reduce the rate of falsely negative trials of efficacious medications and improve the efficiency of analgesic drug development. Therefore, an Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials consensus meeting was convened in which the assay sensitivity of chronic pain trials was reviewed and discussed. On the basis of this meeting and subsequent discussions, the authors recommend consideration of a number of patient, study design, study site, and outcome measurement factors that have the potential to affect the assay sensitivity of RCTs of chronic pain treatments. Increased attention to and research on methodological aspects of clinical trials and their relationships with assay sensitivity have the potential to provide the foundation for an evidence-based approach to the design of analgesic clinical trials and expedite the identification of analgesic treatments with improved efficacy and safety.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., Kerns, R. D., Stucki, G., Allen, R. R., Bellamy, N., et al. (2005) · Pain · doi:10.1016/j.pain.2004.09.012 · Cited by 3,732
Self-citationCore outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
Self-citationClassification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,362
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
The prevention and treatment of missing data in clinical trials
Little, R. J., D'Agostino, R., Cohen, M. L., Dickersin, K., Emerson, S. S., Farrar, J. T., Frangakis, C., Hogan, J. W., Molenberghs, G., Murphy, S. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmsr1203730 · Cited by 1,884
Self-citationEFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationBiological, clinical, and ethical advances of placebo effects
Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61706-2 · Cited by 1,272
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
Gilron, I., Bailey, J. M., Tu, D., Holden, R. R., Weaver, D. F., & Houlden, R. L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042580 · Cited by 1,091
Self-citationThe evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Cited by
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Self-citationThe placebo response in medicine: minimize, maximize or personalize?
Enck, P., Bingel, U., Schedlowski, M., & Rief, W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3923 · Cited by 671
The neuropathic component in persistent postsurgical pain: A systematic literature review
Haroutiunian, S., Nikolajsen, L., Finnerup, N. B., & Jensen, T. S. (2013) · Pain · doi:10.1016/j.pain.2012.09.010 · Cited by 482
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Edwards, R. R., Dworkin, R. H., Turk, D. C., Angst, M. S., Dionne, R., Freeman, R., Hansson, P., Haroutounian, S., Arendt-Nielsen, L., Attal, N., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000602 · Cited by 403
Self-citationThemistocleous, A. C., Ramirez, J. D., Shillo, P. R., Lees, J. G., Selvarajah, D., Orengo, C., Tesfaye, S., Rice, A. S. C., & Bennett, D. L. H. (2016) · Pain · doi:10.1097/j.pain.0000000000000491 · Cited by 313
Self-citationO'Connell, N. E., Wand, B. M., McAuley, J. H., Marston, L., & Moseley, G. L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009416.pub2 · Cited by 244
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
Smith, S. M., Dworkin, R. H., Turk, D. C., McDermott, M. P., Eccleston, C., Farrar, J. T., Rowbotham, M. C., Bhagwagar, Z., Burke, L. B., Cowan, P., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001952 · Cited by 194
Self-citationPsychological Interventions for the Treatment of Chronic Pain in Adults
Driscoll, M. A., Edwards, R. R., Becker, W. C., Kaptchuk, T. J., & Kerns, R. D. (2021) · Psychological Science in the Public Interest · doi:10.1177/15291006211008157 · Cited by 176
Self-citationFarrar, J. T., Troxel, A. B., Haynes, K., Gilron, I., Kerns, R. D., Katz, N. P., Rappaport, B. A., Rowbotham, M. C., Tierney, A. M., Turk, D. C., et al. (2014) · Pain · doi:10.1016/j.pain.2014.05.009 · Cited by 110
Self-citationChien, C.-W., Bagraith, K. S., Khan, A., Deen, M., & Strong, J. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.08.006 · Cited by 108
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
“A high placebo effect has been previously shown in trials of analgesics [235] and thus may mask the positive treatment effect in neuropathic pain trials [236].”
BackgroundRandomised controlled trials may underestimate drug effects: balanced placebo trial design
Lund, K., Vase, L., Petersen, G. L., Jensen, T. S., & Finnerup, N. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084104 · Cited by 72
“trials of pain, depression, and cough [5,11,16,17,28,29].”
Body image in women with primary and secondary provoked vestibulodynia: A controlled study
Maillé, D. L., Bergeron, S., & Lambert, B. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12765 · Cited by 44
Assay sensitivity and study features in neuropathic pain trials: An ACTTION meta-analysis
Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., He, H., McDermott, M. P., Farrar, J. T., Katz, N. P., Lin, A. H., Rappaport, B. A., & Rowbotham, M. C. (2013) · Neurology · doi:10.1212/wnl.0b013e318297ee69 · Cited by 38
“baseline daily pain reports).(12,40) Finally, the retrospective analyses we conducted cannot establish causal relationships between the demographic and clinical factors we examined and assay sensitivity.”
BackgroundSelf-citationUebelacker, L. A., Van Noppen, D., Tremont, G., Bailey, G., Abrantes, A., & Stein, M. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.07.015 · Cited by 38
Metadata
- Authors
- Dworkin, R. H., Turk, D. C., Peirce-Sandner, S., Burke, L. B., Farrar, J. T., Gilron, I., Jensen, M. P., Katz, N. P., Raja, S. N., Rappaport, B. A., Rowbotham, M. C., Backonja, M.-M., Baron, R., Bellamy, N., Bhagwagar, Z., Costello, A., Cowan, P., Fang, W. C., Hertz, S., Jay, G. W., Junor, R., Kerns, R. D., Kerwin, R., Kopecky, E. A., Lissin, D., Malamut, R., Markman, J. D., McDermott, M. P., Munera, C., Porter, L., Rauschkolb, C., Rice, A. S. C., Sampaio, C., Skljarevski, V., Sommerville, K., Stacey, B. R., Steigerwald, I., Tobias, J., Trentacosti, A. M., Wasan, A. D., Wells, G. A., Williams, J., Witter, J., & Ziegler, D.
- Venue
- Pain
- Published
- 2012-06
- Volume
- 153
- Issue
- 6
- Pages
- 1148-1158
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2005540257
- Cited by
- 285
- References
- 98
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.